R1 RCM Inc (RCM) Stock
RCM is no longer traded. R1 RCM was taken private by TowerBrook and CD&R on November 19, 2024.
Each RCM share was exchanged for $14.30 in cash. Prices on this page are historical; the last trade was November 18, 2024 at $14.31.
R1 RCM stock price history
RCM final trading statistics
- Final close
- $14.31
- Final trading day
- Nov 18, 2024
- Market cap at delisting
- $6.04B
- Shares outstanding
- 422.39M
- Final 52-week range
- $8.87 – $15.12
- Avg. volume (final 3 mo.)
- 2,847,949
- All-time high (split-adj.)
- $30.80 · Aug 2011
- All-time low (split-adj.)
- $1.50 · Aug 2016
- Return since IPO
- +5.6%
- Beta
- 0.84
- Book value / share
- $6.66
- Price / book
- 2.15
R1 RCM annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $2.25B | $3.3M | $0.25 |
| FY2022 | $1.81B | -$57.6M | -$0.14 |
| FY2021 | $1.47B | $87.3M | $0.33 |
| FY2020 | $1.27B | $115.2M | $0.09 |
| FY2019 | $1.19B | $12.0M | $0.02 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About R1 RCM Inc
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah. As of November 19, 2024, R1 RCM Inc. was taken private.
R1 RCM stock FAQ
What happened to R1 RCM stock?
R1 RCM was taken private by TowerBrook and CD&R on November 19, 2024. Shareholders received $14.30 in cash for each share. RCM stock stopped trading on the Nasdaq, with a final close of $14.31 on November 18, 2024.
What did R1 RCM shareholders receive?
Each RCM share was converted into $14.30 in cash.
Is RCM stock still trading?
No. RCM was delisted from the Nasdaq on November 19, 2024 and no longer trades on a U.S. exchange.
What was the last price of RCM stock?
RCM closed at $14.31 on its final trading day, November 18, 2024, for a market value of about $6.04B.
What were R1 RCM's revenue and earnings in its last full fiscal year?
R1 RCM reported revenue of $2.25B and net income of $3.3M in fiscal 2023, its last full year as a public company.
When did R1 RCM go public?
R1 RCM Inc stock began trading on May 20, 2010.